These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26178213)
1. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors]. Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213 [TBL] [Abstract][Full Text] [Related]
2. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097 [TBL] [Abstract][Full Text] [Related]
3. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas. Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392 [TBL] [Abstract][Full Text] [Related]
4. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas. Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573 [TBL] [Abstract][Full Text] [Related]
5. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas. Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis. Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972 [TBL] [Abstract][Full Text] [Related]
7. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q. Tiemann K; Heitling U; Kosmahl M; Klöppel G Mod Pathol; 2007 Sep; 20(9):955-60. PubMed ID: 17632456 [TBL] [Abstract][Full Text] [Related]
8. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas. Kim MJ; Jang SJ; Yu E Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228 [TBL] [Abstract][Full Text] [Related]
9. [The clinical characteristics surgical procedures and prognosis of solid pseudopapillary tumor of the pancreas]. Yang H; Li N; Deng WY; Luo SX Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):211-215. PubMed ID: 28316222 [No Abstract] [Full Text] [Related]
10. [Clinicopathologic features, diagnosis and treatment with solid-pseudopapillary tumor of the pancreas: a report of 33 cases]. Yuan CH; Xiu DR; Shi XY; Ma ZL; Li ZF; Tao M; Jia YM; Xiong JW; Zhang TL Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):11-4. PubMed ID: 22490282 [TBL] [Abstract][Full Text] [Related]
11. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors. Lu H; Allende D; Liu X; Zhang Y Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981 [TBL] [Abstract][Full Text] [Related]
12. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas. Jiang Y; Xie J; Wang B; Mu Y; Liu P Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118 [TBL] [Abstract][Full Text] [Related]
13. Solid pseudopapillary tumor of the pancreas: emphasis on differential diagnosis from aggressive tumors of the pancreas. Aydiner F; Erinanç H; Savaş B; Erden E; Karayalçin K Turk J Gastroenterol; 2006 Sep; 17(3):219-22. PubMed ID: 16941259 [TBL] [Abstract][Full Text] [Related]
14. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration. Ahmed A; VandenBussche CJ; Ali SZ; Olson MT Diagn Cytopathol; 2016 Jan; 44(1):10-3. PubMed ID: 26402138 [TBL] [Abstract][Full Text] [Related]
15. Solid-papillary tumors of the pancreas: histopathology. Santini D; Poli F; Lega S JOP; 2006 Jan; 7(1):131-6. PubMed ID: 16407635 [TBL] [Abstract][Full Text] [Related]
16. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas. Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515 [TBL] [Abstract][Full Text] [Related]
17. Solid pseudopapillary neoplasm of pancreas: Two case reports. Gurzu S; Bara T; Sincu M; Gabos S; Vlad DM; Bara T; Beres H; Jung I Medicine (Baltimore); 2019 Jul; 98(29):e16455. PubMed ID: 31335701 [TBL] [Abstract][Full Text] [Related]
18. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor. Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340 [TBL] [Abstract][Full Text] [Related]
19. Solid pseudopapillary tumor of the pancreas: E-cadherin, β-catenin, CD99 new useful markers with characteristic expression (about two case reports). Salwa N; Rym D; Raoudha D; Lamia C; Imen A; Maha D; Karima M Pan Afr Med J; 2021; 40():110. PubMed ID: 34887984 [TBL] [Abstract][Full Text] [Related]
20. [Clear cell papillary renal cell carcinoma: a distinct low-grade renal tumour]. Yang X; Miao N; Gan H; Wang L; Wang C Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):372-6. PubMed ID: 26704829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]